News alert: FDA approves first-ever vaccine for older adults against RSV, or respiratory syncytial virus

Trial data showed the new vaccine, developed by GlaxoSmithKline, reduced severe respiratory synctial virus, or RSV, by 94% in older adults.

Read in browser Read in browser Wed May 3 2023 FDA approves first-ever RSV vaccine, shots to be available for older adults Trial data showed the new vaccine, developed by GlaxoSmithKline, reduced severe respiratory synctial virus, or RSV, by 94% in older adults. READ FULL STORY→ READ FULL STORY→ Advertisement A Better News Alert We've redesigned your News Alerts to have a cleaner look and feel. Let us know what you think about it. SHARE YOUR THOUGHTS ➔ SHARE YOUR THOUGHTS ➔ SUBSCRIBE TODAY Our Reporting. Your Stories. • Full access to subscriber-only content on all devices.   • Share bonus subscription with a family member or friend.   • The universal eNewspaper, the digital version of our print paper , plus bonus monthly magazines and hundreds of local papers.   • Original reporting of our hometown teams, from high school sports to the pros. SUBSCRIBE TODAY SUBSCRIBE TODAY Newsletters   |    eNewspaper   |   Crosswords Follow Us Problem viewing email? View in browser Unsubscribe  •   Manage Newsletters  •  Terms of Service  •   Privacy Policy/Your California Privacy Rights  •  Privacy Notice  •   Do Not Sell My Info/Cookie Policy  •  Feedback